Severe neurodegeneration with impaired autophagy mechanism triggered by ostm1 deficiency.

J Biol Chem

From the Institut de Recherches Cliniques de Montréal (IRCM), Département de Médecine, Université de Montréal, Montréal, Québec H2W 1R7, Canada, the Department of Medicine, Division of Experimental Medicine, McGill University, Montréal, Québec H3A 1A3, Canada,

Published: May 2014

Loss of Ostm1 leads to the most severe form of osteopetrosis in mice and humans. Because functional rescue of the osteopetrotic defect in these mice extended their lifespan from ∼3 weeks to 6 weeks, this unraveled a second essential role of Ostm1. We discovered that Ostm1 is highly expressed in the mouse brain in neurons, microglia, and astrocytes. At 3-4 weeks of age, mice with Ostm1 loss showed 3-10-fold stimulation of reactive gliosis, with an increased astrocyte cell population and microglia activation. This inflammatory response was associated with marked retinal photoreceptor degeneration and massive neuronal loss in the brain. Intracellular characterization of neurons revealed abnormal storage of carbohydrates, lipids, and ubiquitinated proteins, combined with marked accumulation of autophagosomes that causes frequent axonal swelling. Stimulation of autophagy was provided by specific markers and by significant down-regulation of the mammalian target of rapamycin signaling, identifying a cellular pathologic mechanism. A series of transgenic mouse lines specifically targeted to distinct central nervous system cell subpopulations determined that Ostm1 has a primary and autonomous role in neuronal homeostasis. Complete functional complementation demonstrated that the development of severe and rapid neurodegeneration in these mice is independent of the hematopoietic lineage and has clinical implications for treatment of osteopetrosis. Importantly, this study establishes a novel neurodegenerative mouse model critical for understanding the multistep pathogenic cascade of cellular autophagy disorders toward therapeutic strategy design.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022863PMC
http://dx.doi.org/10.1074/jbc.M113.537233DOI Listing

Publication Analysis

Top Keywords

ostm1
6
severe neurodegeneration
4
neurodegeneration impaired
4
impaired autophagy
4
autophagy mechanism
4
mechanism triggered
4
triggered ostm1
4
ostm1 deficiency
4
deficiency loss
4
loss ostm1
4

Similar Publications

Long non-coding RNA OSTM1-AS1 promotes renal cell carcinoma progression by sponging miR-491-5p and upregulating MMP-9.

Sci Rep

January 2025

Translational Research Laboratory for Urology, The Key Laboratory of Ningbo City, Ningbo Clinical Research Center for Urological Disease, Comprehensive Urogenital Cancer Center, The First Affiliated Hospital of Ningbo University, #59 Liuting Street, Ningbo, 315010, Zhejiang, China.

Long noncoding RNAs (lncRNAs) have been recognized as essential regulators in various human malignancies. Hundreds of lncRNAs were known to be abnormally expressed in renal cell carcinoma (RCC) through a lncRNA expression microarray, among which lncRNA OSTM1 antisense RNA 1(OSTM1-AS1) was revealed as one of the most abundant lncRNAs. However, the function of OSTM1-AS1 in RCC remains unknown.

View Article and Find Full Text PDF

Gain-of-function variants in CLCN7 cause hypopigmentation and lysosomal storage disease.

J Biol Chem

July 2024

Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany; NeuroCure Cluster of Excellence, Charité Universitätsmedizin, Berlin, Germany. Electronic address:

Together with its β-subunit OSTM1, ClC-7 performs 2Cl/H exchange across lysosomal membranes. Pathogenic variants in either gene cause lysosome-related pathologies, including osteopetrosis and lysosomal storage. CLCN7 variants can cause recessive or dominant disease.

View Article and Find Full Text PDF

Microglia, professional phagocytic cells of the brain, rely upon the appropriate activation of lysosomes to execute their immune and clearance functions. Lysosomal activity is, in turn, modulated by a complex network of over 200 membrane and accessory proteins that relay extracellular cues to these key degradation centers. The ClC-7 chloride (Cl-)-proton (H+) antiporter (also known as CLCN7) is localized to the endolysosomal compartments and mutations in CLCN7 lead to osteopetrosis and neurodegeneration.

View Article and Find Full Text PDF

ClC-7 is a ubiquitously expressed voltage-gated Cl/H exchanger that critically contributes to lysosomal ion homeostasis. Together with its β-subunit Ostm1, ClC-7 localizes to lysosomes and to the ruffled border of osteoclasts, where it supports the acidification of the resorption lacuna. Loss of ClC-7 or Ostm1 leads to osteopetrosis accompanied by accumulation of storage material in lysosomes and neurodegeneration.

View Article and Find Full Text PDF
Article Synopsis
  • - ClC-6 and ClC-7 are intracellular proteins that help regulate chloride (Cl) and hydrogen ions (H) in late endosomes and lysosomes, but they function differently, with ClC-7 needing another protein called Ostm1 to operate properly.
  • - Experiments showed that lower levels of external Cl reduce ClC-6 function, while they enhance ClC-7's activity, particularly under acidic conditions or low internal Cl levels.
  • - The study highlighted unique functions and responses of both transporters, indicating that ClC-7's ability to handle Cl may contribute to disease processes like osteopetrosis, emphasizing the need for balanced ion levels in cellular environments.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!